atenolol and ER-Negative PR-Negative HER2-Negative Breast Cancer studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research Excerpts

Excerpt	Relevance	Reference
"Metformin can induce breast cancer (BC) cell apoptosis and reduce BC local and metastatic growth in preclinical models."	7.83	Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. ( Albini, A; Bertolini, F; Calleri, A; Dallaglio, K; Gregato, G; Labanca, V; Mancuso, P; Noonan, DM; Orecchioni, S; Reggiani, F; Rossi, T; Talarico, G, 2016)
"Metformin can induce breast cancer (BC) cell apoptosis and reduce BC local and metastatic growth in preclinical models."	3.83	Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells. ( Albini, A; Bertolini, F; Calleri, A; Dallaglio, K; Gregato, G; Labanca, V; Mancuso, P; Noonan, DM; Orecchioni, S; Reggiani, F; Rossi, T; Talarico, G, 2016)

Research

Studies (1)

Authors

Other Studies

1 other study available for atenolol and ER-Negative PR-Negative HER2-Negative Breast Cancer

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Talarico, G	1
Orecchioni, S	1
Dallaglio, K	1
Reggiani, F	1
Mancuso, P	1
Calleri, A	1
Gregato, G	1
Labanca, V	1
Rossi, T	1
Noonan, DM	1
Albini, A	1
Bertolini, F	1